Enveric Biosciences, Inc. (ENVB)
NASDAQ: ENVB · IEX Real-Time Price · USD
0.470
-0.019 (-3.87%)
At close: Jul 19, 2024, 4:00 PM
0.520
+0.050 (10.64%)
Pre-market: Jul 22, 2024, 6:52 AM EDT
Enveric Biosciences Market Cap
Enveric Biosciences has a market cap or net worth of $3.74 million as of July 22, 2024. Its market cap has decreased by -37.70% in one year.
Market Cap
3.74M
Enterprise Value
-2.62M
1-Year Change
-37.70%
Ranking
Category
Stock Price
$0.47
Market Cap Chart
Since November 16, 2017, Enveric Biosciences's market cap has decreased from $137.90M to $3.74M, a decrease of -97.29%. That is a compound annual growth rate of -41.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 3.60M | 20.00% |
| Dec 29, 2023 | 3.00M | -30.23% |
| Dec 30, 2022 | 4.30M | -85.27% |
| Dec 31, 2021 | 29.20M | 265.00% |
| Dec 31, 2020 | 8.00M | 40.35% |
| Dec 31, 2019 | 5.70M | -17.39% |
| Dec 31, 2018 | 6.90M | -85.98% |
| Dec 29, 2017 | 49.20M | -64.32% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sintx Technologies | 3.82M |
| Onconetix | 3.80M |
| Regional Health Properties | 3.77M |
| Bio-Path Holdings | 3.77M |
| Venus Concept | 3.75M |
| Fresh2 Group | 3.70M |
| Scinai Immunotherapeutics | 3.68M |
| Applied DNA Sciences | 3.63M |